BLOG/🇺🇸United States··daily

US Corporate Distress Financial Stress SEC Filings — March 18, 2026

USA Corporate Distress & Bankruptcy

31 high priority31 total filings analysed

Executive Summary

Across 31 filings in the USA Corporate Distress & Bankruptcy stream, a dominant theme is aggressive liquidity pursuits through debt facilities, equity issuances, note extensions, and credit amendments, with 18 companies (58%) announcing new/expanded financing amid potential distress signals like Nasdaq delisting notices in 2 cases and dilutive convertible notes in 5. Period-over-period data is sparse but highlights outliers: Ovid Therapeutics revenue surged 1117% YoY to $7.3M with opex down 20% to $49.7M and net loss halved to $17.4M, contrasting minimal quantitative trends elsewhere. Positive catalysts include M&A (e.g., Independent Bank's $70.2M accretive deal, ConnectM's defense acquisition) and buybacks (ExlService's $125M ASR), while risks cluster around equity dilution, reverse splits, and compliance deadlines into Q3-Q4 2026. Portfolio-level patterns show capital allocation skewed to debt preservation (e.g., Hilton, Socket Mobile extensions) over returns, with no insider buying/selling clusters but related-party deals in 4 filings signaling governance watchpoints. Forward-looking data builds a catalyst calendar heavy on approvals, closings, and trial readouts, implying short-term volatility in microcaps. Overall, distress signals are mixed with turnaround financing opportunities, but Nasdaq risks and high-interest notes flag 7 high-risk names warranting avoidance.

Tracking the trend? Catch up on the prior US Corporate Distress Financial Stress SEC Filings digest from March 17, 2026.

Investment Signals(12)

  • FY2025 revenue +1117% YoY to $7.3M from $0.6M, opex -20% YoY to $49.7M, net loss -34% to $17.4M; $60M placement funds ops to late 2028/2029, OV329 Phase 2 advances Q4 2026

  • $125M ASR under $500M program delivers 3.35M shares (~$100M initial), funded by cash/borrowings, signals strong capital allocation confidence

  • Hyperfine(BULLISH)

    Secures $40M loan facility (8x$5M tranches) with guarantors, extending to 2027, bolsters liquidity without immediate dilution

  • Amendment #12 extends rev facility maturity 5yrs, raises LC/swingline limits to $500M/$200M, SOFR margins start 1.00%

  • $2.25B term loan with top lenders enhances liquidity, no covenant breaches noted

  • $300M incremental term loans for corp purposes, no performance declines, pro forma covenant compliance

  • M&A amendment sweetens ASM deal to 0.053 CDIs + A$0.13 cash/share, court/shareholder approvals pending

  • $70.2M HCB merger 6% accretive to 2027 EPS, 3.4yr TBV earn-back, combined $6.1B assets Q3 2026 close

  • Acquires HKA ($2M 2025 rev) with 400k shares, targets $50B defense market via AI integration

  • 1:500 reverse split approved by 90.3% votes aids uplisting, reduces shares to 0.83M

  • Appoints experienced director per Stilwell standstill to 2029, strengthens governance

  • $3M shares + $1.5M 3yr investment for Penn State NIL consulting, resale reg by Apr 26 2026

Risk Flags(10)

Opportunities(8)

Sector Themes(6)

  • Financing Extensions/Amendments Surge

    9/31 (29%) filings (Hilton #12, Socket 2yrs, FTI incremental, CIM #5) extend maturities/access without cuts, prioritizing debt rollover over equity in distress context; implies manageable leverage but rising SOFR exposure

  • Nasdaq Delisting Pressures

    2/31 microcaps (CalciMedica multi-fail, Glimpse bid) miss rules, 180-day windows to Sep 2026; common in biotech/tech, reverse splits (Elvictor) as frequent remedy

  • Dilutive Microcap Raises

    8/31 (26%) issue conv notes/equity (Artelo bridges, ECD $12.48M total, Mag 10M shares), often related-party/high OID; avg floors ~$0.10 signals deep distress pricing vs peers

  • M&A/Turnaround Activity

    5/31 pursue deals (RocketFuel assets, Independent $70M accretive, ConnectM defense, Energy Fuels intl), 80% mixed/positive sentiment; avg 5-6% EPS acc + scale implies consolidation alpha

  • Biotech Revenue Outliers

    Ovid +1117% YoY contrasts flat/undisclosed peers; trial funding ($60M place) funds to 2029 vs typical cash burns, highlights selective growth amid distress

  • REIT/Finance Repo Deals

    3/31 (BrightSpire, CIM, U-Haul transfer) amend repos with +500bps default spreads, min fees $25k; stable liens signal collateralized liquidity preference

Watch List(8)

Filing Analyses(31)
Laser Photonics Corp8-Kneutralmateriality 7/10

18-03-2026

Laser Photonics Corp filed an 8-K on March 18, 2026 (AccNo: 0001493152-26-010669, Size: 658 KB), reporting under Item 1.01 (Entry into a Material Definitive Agreement), Item 3.02 (Unregistered Sales of Equity Securities), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific transaction values, financial metrics, period-over-period comparisons, or quantitative impacts are disclosed. This is a multi-item filing with no details on positive or negative effects provided.

ROCKETFUEL BLOCKCHAIN, INC.8-Kneutralmateriality 9/10

18-03-2026

RocketFuel Blockchain, Inc. entered a non-binding term sheet on March 13, 2026, with RPay, Inc. and RPoints, Inc. for the proposed sale of its payments business assets to RPay and loyalty/rewards business assets to RPoints. Consideration includes buyers assuming $1.5M in senior deferred compensation liabilities, quarterly earn-out payments of 20% of payments business net revenue up to $2.5M aggregate or 2 years, and warrants for 20% fully diluted ownership in each buyer with fixed repurchase floors of $1.5M (RPay) and $0.2M (RPoints). The Company retains its corporate franchise and cash reserves, with the Board approving the interested-party transaction; the term sheet is non-binding except for exclusivity, confidentiality, and fees.

  • ·Term Sheet filed as Exhibit 10.1
  • ·Anticipated execution of definitive asset purchase agreements
  • ·Transaction approved by Board despite interested nature
Ovid Therapeutics Inc.8-Kmixedmateriality 9/10

18-03-2026

Ovid Therapeutics announced favorable safety and tolerability for the 7 mg dose of OV329, advancing Phase 2 trials in focal onset seizures (FOS) and expanding into TSC seizures (Q4 2026) and infantile spasms (2027), funded by a $60.0M private placement. OV4071 received Phase 1 clearance in Australia, with cash of $90.4M funding operations into late 2028 (potentially 2029 with $53.9M warrant exercises). Full-year 2025 revenue rose to $7.3M from $0.6M YoY while operating expenses declined to $49.7M from $62.5M, yielding a reduced net loss of $17.4M vs $26.4M; however, Q4 operating expenses increased to $13.0M from $10.8M YoY.

  • ·No treatment-related adverse events or serious adverse events observed across OV329 doses tested, including 7 mg cohort.
  • ·Extensive ophthalmic assessments showed no evidence of retinal changes with OV329.
  • ·OV4071 initially focused on psychosis associated with Parkinson’s disease and Lewy body dementia; ketamine challenge study planned mid-2026.
  • ·Private placement shares at $2.01 per share; pre-funded warrants at $2.009 with $0.001 exercise price.
  • ·Q4 2025 net income per share $0.06 vs Q4 2024 loss per share $0.13; full year 2025 loss per share $0.23 vs 2024 $0.37.
ExlService Holdings, Inc.8-Kmixedmateriality 8/10

18-03-2026

ExlService Holdings, Inc. entered into a $125M accelerated share repurchase (ASR) transaction with Morgan Stanley on March 16, 2026, receiving an initial 3,346,720 shares worth approximately $100M, as part of a $500M board-approved share repurchase program. The final settlement is expected by Q2 2026, with potential for additional shares or cash adjustments. Separately, board member Nitin Sahney notified he will not stand for re-election at the 2026 annual meeting, citing no disagreements with management or the board.

  • ·ASR funded using cash on hand and borrowings under existing credit facility.
  • ·Final number of shares based on Rule 10b-18 VWAP over valuation period, less discount and adjustments.
  • ·ASR Agreement attached as Exhibit 10.1.
Hyperfine, Inc.8-Kpositivemateriality 9/10

18-03-2026

Hyperfine, Inc. entered into a Loan and Security Agreement dated March 18, 2026, with Horizon Technology Finance Corporation as Collateral Agent and Lender, establishing eight loan commitments (Loans A-H) each for $5M, for a total facility of up to $40M. Loans A-C terminate on the Closing Date, while Loans D-H have commitment termination dates of December 31, 2027. Hyperfine Operations, Inc. and Liminal Sciences, Inc. serve as guarantors, with collateral securing the obligations.

  • ·Affiliate defined as owning/controlling 10% or more of stock.
  • ·Excluded Property includes real property interests other than fee ownership, certain titled assets, and up to 65% of foreign subsidiary voting stock.
Hilton Worldwide Holdings Inc.8-Kpositivemateriality 8/10

18-03-2026

Hilton Domestic Operating Company Inc., an indirect subsidiary of Hilton Worldwide Holdings Inc., entered into Amendment No. 12 to its Credit Agreement on March 18, 2026, extending the maturity of the senior secured Revolving Credit Facility to the earlier of five years from the amendment date or 91 days prior to existing term loan maturities. The amendment increases the letter of credit sublimit from $250M to $500M and the swingline borrowing sublimit from $100M to $200M, while setting SOFR-based interest margins starting at 1.00% subject to leverage-based step-ups. No declines or capacity reductions were reported.

  • ·Interest margin for SOFR loans starts at 1.00% when first lien net leverage <=1.50x, with 0.25% step-ups for higher leverage tiers (<=2.50x, <=3.50x, >3.50x).
  • ·Original Credit Agreement dated October 25, 2013; this is Amendment No. 12.
Phillips 668-Kpositivemateriality 9/10

18-03-2026

Phillips 66 Company, as borrower, and Phillips 66, as initial guarantor, entered into a $2.25 billion term loan credit agreement on March 18, 2026, with Mizuho Bank, Ltd. as administrative agent and various lenders including Bank of America, N.A., PNC Bank, N.A., The Toronto-Dominion Bank, New York Branch, Truist Bank, and MUFG Bank, Ltd. as co-syndication agents. The facility provides access to significant liquidity with standard terms including ABR and Term SOFR-based interest rates, but includes covenants on liens, indebtedness, and fundamental changes. No prior period comparisons or performance metrics are disclosed.

BrightSpire Capital, Inc.8-Kneutralmateriality 7/10

18-03-2026

BrightSpire Credit 9, LLC, a subsidiary of BrightSpire Capital, Inc., entered into a Master Repurchase Agreement with JPMorgan Chase Bank, National Association, dated March 12, 2026, filed as Exhibit 10.1 in the 8-K on March 18, 2026. The agreement enables repurchase transactions where the Seller transfers rights to Eligible Assets (such as senior mortgage loans) to the Buyer for funds, with a commitment to repurchase, effectively providing secured financing. No specific facility size, advance rates, or spreads are detailed in the provided content, which focuses on definitions, covenants, and exhibits referencing a related Fee Letter.

  • ·Filing Type: 8-K (Items 1.01 - Entry into Material Definitive Agreement, 2.03 - Creation of Direct Financial Obligation, 9.01 - Exhibits)
  • ·Agreement governed by U.S. law, with security interest granted to Buyer over Purchased Assets
  • ·Applicable Spread post-Event of Default increases by 500 basis points (5.0%)
CalciMedica, Inc.8-Knegativemateriality 9/10

18-03-2026

CalciMedica, Inc. received Nasdaq notices on March 13, 2026, for failing the MVLS Requirement (market value below $35M for 30 consecutive business days), and also not meeting stockholders' equity or net income standards under Listing Rules 5550(b)(1) and 5550(b)(3); a separate notice on March 16, 2026, cited failure of the minimum bid price requirement (below $1.00/share for 30 days). The company has 180 calendar days to regain compliance—until September 9, 2026, for MVLS/equity/net income, and September 14, 2026, for bid price—with options like reverse stock split, but there is no assurance of success and trading continues uninterrupted under symbol CALC.

  • ·Company address: 505 Coast Boulevard South, Suite 307, La Jolla, California 92037
  • ·Trading symbol: CALC
  • ·Notifications have no immediate effect on listing or trading
Mag Magna Corp8-Kneutralmateriality 7/10

18-03-2026

Mag Magna Corp, an emerging growth company, entered into consulting services agreements since February 13, 2026, issuing 8,700,000 shares of common stock to 13 third-party consultants for services supporting its rare earth element strategies, under the 2026 Mag Magna Corp. Stock Incentive Plan and Form S-8 (SEC File No. 333-293453). Separately, 1,300,000 shares valued at $100,000 ($0.077 per share) were issued to Eric Newlan of Newlan Law Firm, PLLC, under a legal services agreement dated March 6, 2026, extending through September 30, 2026. All agreements prohibit consultants from engaging in capital-raising or securities promotion activities.

  • ·Form S-8 Registration Statement SEC File No. 333-293453
  • ·Legal services under Newlan Agreement through September 30, 2026
  • ·Consulting services agreements form filed as Exhibit 10.1; Newlan Agreement as Exhibit 10.2
FTI CONSULTING, INC8-Kpositivemateriality 8/10

18-03-2026

FTI Consulting, Inc. entered into an Incremental Amendment to its Second Amended and Restated Credit Agreement dated November 21, 2022, on March 17, 2026, to obtain $300M in new 2026 Incremental Term Loans from participating lenders led by BofA Securities, Inc. The proceeds will be used for general corporate purposes, with the amendment effective upon satisfaction of conditions including executed documents, representations and warranties, no defaults, legal opinions, fee payments, and pro forma compliance with financial covenants. No performance declines or flat metrics are reported in this debt facility expansion.

  • ·Amendment amends Existing Credit Agreement without consent of other lenders
  • ·2026 Incremental Term Loans form a separate class from existing Revolving Credit Facility
  • ·Arrangers: BofA Securities, Inc. (joint lead arranger and sole book manager), JPMorgan Chase Bank, N.A., HSBC Securities (USA) Inc., and Truist Securities, Inc. (joint lead arrangers and syndication agents)
  • ·Documentation agents: PNC Bank, National Association and TD Bank N.A.
  • ·Conditions include certificates of Responsible Officers, favorable legal opinions, and payment of attorney costs and fees
Lake Shore Bancorp, Inc. /MD/8-Kpositivemateriality 7/10

18-03-2026

Lake Shore Bancorp, Inc. appointed Dennis Pollack to the Boards of Directors of the Company and Lake Shore Bank effective March 17, 2026, pursuant to a standstill agreement with The Stilwell Group, which remains in effect until the 2029 Annual Meeting of Stockholders. The Board views the addition as strengthening governance and expertise in key oversight areas, with no financial impacts or performance metrics disclosed. Stilwell congratulated the appointment, citing Pollack's extensive banking experience.

  • ·Bank headquartered in Dunkirk, New York, with branches including four in Chautauqua County and six in Erie County.
  • ·Agreement includes customary provisions regarding standstill, voting commitments, and other matters.
American Picture House Corp8-Kneutralmateriality 8/10

18-03-2026

American Picture House Corp (APHP) disclosed in an 8-K filing on March 18, 2026, its entry into a material definitive agreement (Item 1.01), creation of a direct financial obligation (Item 2.03), and unregistered sales of equity securities (Item 3.02). Details of the agreement are contained in Exhibit 10.1. No specific financial terms or performance metrics were detailed in the provided filing content.

  • ·Filing Type: 8-K
  • ·Subcategory: Material Agreement Entry
Elvictor Group, Inc.8-Kpositivemateriality 8/10

18-03-2026

Elvictor Group Inc. (ELVG) announced approval by its Board and stockholders representing 90.3% of voting power for a 1-for-500 reverse stock split, reducing outstanding common shares from approximately 414.4 million to 0.83 million while keeping authorized shares unchanged. The move is intended to support a higher per-share trading price and the company's uplisting strategy to a national securities exchange. No fractional shares will be issued, with any fractions rounded up to the nearest whole share.

  • ·Reverse split approved via written consent without a stockholder meeting.
  • ·Trading symbol ELVG will temporarily append 'D' (ELVGD) for 20 business days starting March 17, 2026.
  • ·Split expected to become effective after required notice period and filings with State of Nevada and FINRA.
Lottery.com Inc.8-Kneutralmateriality 8/10

18-03-2026

Lottery.com Inc. filed an 8-K on 2026-03-18 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement), Item 3.02 (Unregistered Sales of Equity Securities), and Item 9.01 (Financial Statements and Exhibits). No specific details on the agreement, obligation, equity sales, transaction values, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no information on filing timeliness relative to the event.

Nuburu, Inc.8-Kneutralmateriality 8/10

18-03-2026

Nuburu, Inc. entered into a Bond Subscription Agreement on March 12, 2026, with Supply@ME Stock Company 3 S.r.l. (SYME 3), subscribing to initial bonds with a nominal value of EUR 5.25 million maturing in March 2029, funded by offsetting EUR 4.82 million in prior advance payments under a related $5.15 million convertible facility from March 2025. SYME 3 may issue up to EUR 30 million in such bonds to fund Tekne S.p.A.'s inventory, secured by Italian law pledges over inventory, bank accounts, and receivables. The transaction involves related parties, as Executive Chairman Alessandro Zamboni is also SYME's founder and CEO, with bonds accruing interest at 3-month Euribor + 7.5% per annum, capped at 12%.

  • ·First interest payment due July 8, 2026, on the 8th of January, April, July, and October.
  • ·Bonds secured by non-possessory pledge (Pegno Non Possessorio) over Tekne inventory, pledge over SYME 3 bank account, and pledge over receivables/VAT receivables.
  • ·SYME 3 may redeem early after first anniversary or with 120 days' notice; Company may request mandatory redemption with 120 days' notice.
ENERGY FUELS INC8-Kpositivemateriality 9/10

18-03-2026

Energy Fuels Inc. entered into a Deed of Amendment and Restatement on March 12, 2026 (March 13 AWST), with Australian Strategic Materials Limited (ASM) to modify the consideration structure for its acquisition of ASM via a court-approved scheme of arrangement. Scheme shareholders will now receive 0.053 Energy Fuels CDIs (or common shares at election) plus A$0.13 cash per ASM share, replacing a previously planned special dividend of up to A$0.13 with no other material changes to the January 20, 2026 Scheme Implementation Deed. The transaction remains subject to court, shareholder, and regulatory approvals, with forward-looking risks including potential non-implementation.

  • ·Filing incorporates by reference Items 1.01 and 3.02 from January 26, 2026 8-K.
  • ·Deed filed as Exhibit 10.1.
  • ·Securities: Common shares (UUUU on NYSE American, EFR on TSX).
NewtekOne, Inc.8-Kneutralmateriality 7/10

18-03-2026

NewtekOne, Inc. entered into a Securities Distribution Agreement on March 13, 2026 (effective March 12, 2026) with B. Riley Securities, Inc., Compass Point Research and Trading, LLC, and Roth Capital Partners, LLC, enabling at-the-market offerings of up to $50 million aggregate principal amount/liquidation preference of specified senior notes and depositary shares. The securities will be issued under the Company's shelf registration statement on Form S-3 (File No. 333-269452) and a prospectus supplement filed on March 13, 2026. No sales have occurred under this agreement to date.

  • ·Agreement filed as Exhibit 1.1
  • ·Prospectus Supplement filed with SEC on March 13, 2026
  • ·Shelf registration statement: Form S-3 (File No. 333-269452)
  • ·Company principal executive offices: 4800 T Rex Avenue, Suite 120, Boca Raton, Florida 33431
INDEPENDENT BANK CORP /MI/8-Kmixedmateriality 10/10

18-03-2026

Independent Bank Corporation (NASDAQ: IBCP) announced a definitive merger agreement to acquire HCB Financial Corp. (OTCPK: HCBN) in a cash and stock transaction valued at approximately $70.2M, based on IBCP's closing stock price of $33.13 on March 17, 2026, resulting in a combined entity with $6.1B in total assets, $5.3B in deposits, and $4.7B in loans as of December 31, 2025. The deal is expected to be 6% accretive to IBCP's 2027 EPS with a projected CET1 ratio of 11.5% post-closing; however, it involves 4% tangible book value per share dilution, expected to earn back in 3.4 years. The transaction awaits regulatory and shareholder approvals and is targeted to close early in Q3 2026.

  • ·IBCP to issue 1.590 shares of common stock plus $17.51 cash per outstanding HCB share.
  • ·Conference call scheduled for March 19, 2026 at 9:00am ET with presentation slides.
  • ·One HCB director to join IBCP and Independent Bank boards post-merger.
SOCKET MOBILE, INC.8-Kneutralmateriality 7/10

18-03-2026

Socket Mobile, Inc. entered into a Secured Subordinated Convertible Note Extension Agreement on March 18, 2026, extending the maturity of its $1.6M secured subordinated convertible notes from May 26, 2026, to May 26, 2028, with all other terms unchanged. The notes were originally issued on May 26, 2023. Due to involvement of related parties Charlie Bass (Chairman) and Bill Parnell (director), the extension was approved by a special committee of disinterested directors.

  • ·Previous disclosure of original note issuance in 8-K filed May 30, 2023
  • ·Extension effective as of March 18, 2026
American Picture House Corp8-Kpositivemateriality 7/10

18-03-2026

On March 12, 2026, American Picture House Corporation's Board approved the Multi-Film Investment and Compensation Agreement with SSS Entertainment, LLC, effective January 27, 2026, covering films POSE, MOTION, and an additional SSS-produced film, with equity-based incentives. The Board also ratified Amendment No. 1 to the APHP/SSS Agreement, effective December 29, 2025, extending the POSE option and acquiring additional rights to BARRON’S COVE, including an equity settlement alternative. In connection, the Company is obligated to issue $350,000 in common stock value to Bannor Michael MacGregor and The Noah Morgan Private Family Trust.

  • ·Agreements filed as Exhibits 10.1 and 10.2
  • ·Equity issuance exempt under Section 4(a)(2) and/or Rule 506 of Regulation D
  • ·Shares not yet issued as of filing date
Digital Brands Group, Inc.8-Kpositivemateriality 8/10

18-03-2026

Digital Brands Group, Inc. (DBGI) entered into a three-year Consulting Agreement with Athlete Capital Sports LLC on March 12, 2026, for consulting services related to The Pennsylvania State University’s name, image, and likeness (NIL) program, issuing shares valued at $3M based on a volume-weighted average price or lower closing price preceding April 11, 2026. As additional consideration, DBGI agreed to invest $500,000 per year for three years into University student-athlete funds directed by Athlete Capital Sports. The agreement includes a guaranteed make-whole provision on the shares and requires filing a resale registration statement by April 26, 2026.

  • ·Agreement term: March 12, 2026 to March 12, 2029
  • ·Share Delivery Date: April 11, 2026
  • ·Resale Registration Statement filing deadline: April 26, 2026
  • ·Shares subject to guaranteed make-whole provision through the later of 15 months from Effective Date or 6 months post-registration effectiveness
  • ·Athlete Capital Sports appoints DBGI CEO John Hilburn Davis IV as proxy for voting the Shares
  • ·Shares issued in reliance on Section 4(a)(2) exemption from Securities Act registration
ARTELO BIOSCIENCES, INC.8-Knegativemateriality 8/10

18-03-2026

Artelo Biosciences, Inc. entered into securities purchase agreements on March 12, 2026, issuing 12% bridge notes to Vanquish Funding Group Inc. (principal $237,300, proceeds $210,000) and Boot Capital LLC (principal $113,000, proceeds $100,000), raising $310,000 gross for general working capital amid high costs including original issue discounts and $10,000 legal fees. The notes mature January 15, 2027, are prepayable without penalty, but feature risky terms like 150% default acceleration and conversion rights at a discount (greater of $0.125 or 75% of recent low trading price), capped at 4.99% beneficial ownership to limit immediate dilution.

  • ·Notes issued in reliance on Section 4(a)(2) and Rule 506(b) of Regulation D, unregistered securities.
  • ·Conversion price is the greater of $0.125 or 75% of the lowest trading price over the prior 10 trading days.
  • ·Exhibits include Purchase Agreements (10.1, 10.2) and Notes (10.3, 10.4).
Glimpse Group, Inc.8-Knegativemateriality 9/10

18-03-2026

On March 13, 2026, The Glimpse Group, Inc. received a Nasdaq notification for failing the minimum bid price requirement, as its common stock (GGRP) closed below $1.00 per share for 30 consecutive business days, violating Nasdaq Marketplace Rule 5550(a)(2). The company has 180 calendar days until September 9, 2026, to regain compliance by closing at or above $1.00 for 10 consecutive business days, with no immediate effect on trading or operations. Failure to comply may lead to delisting, though a potential second 180-day period is available if other listing standards are met, and the company may pursue measures like a reverse stock split.

  • ·Trading symbol: GGRP on Nasdaq Capital Market
  • ·Company qualifies as an emerging growth company
  • ·Notification has no immediate effect on SEC reporting requirements
ENZON PHARMACEUTICALS, INC.8-Kneutralmateriality 5/10

18-03-2026

Enzon Pharmaceuticals, Inc. entered into the Tenth Amendment to its Section 382 Rights Agreement on March 18, 2026, extending the Final Expiration Date of the rights from noon, New York City time on March 18, 2026, to noon on March 24, 2026. This follows a series of nine prior amendments since 2021 that repeatedly adjusted the expiration date, most recently shortening it multiple times in early 2026. Management states the extension is in the best interests of the Company and its stockholders, with no other changes to the Rights Agreement.

  • ·Rights Agreement originally dated August 14, 2020.
  • ·Previous amendments: First (June 2, 2021), Second (May 16, 2024), Third (March 31, 2025), Fourth (August 13, 2025), Fifth (September 30, 2025), Sixth (December 23, 2025), Seventh (January 30, 2026), Eighth (February 27, 2026), Ninth (March 10, 2026).
SRx Health Solutions, Inc.8-Kneutralmateriality 8/10

18-03-2026

SRx Health Solutions Inc. (SRXH) Board of Directors adopted a resolution on March 10, 2026, to create 12,500 shares of Series B Convertible Preferred Stock with a par value of $0.001 per share, pursuant to a Securities Purchase Agreement. The new series ranks pari passu with existing Series A Convertible Preferred Stock and senior to common stock regarding dividends and liquidation preferences, and is convertible into common stock at a price of $0.3182 per share. Default dividends accrue at 15% per annum upon triggering events.

  • ·Preferred Shares rank junior to any Senior Preferred Stock and senior to Junior Stock (common stock).
  • ·Conversion mechanics require notice to Company with Share Delivery Deadline of 1 Trading Day.
ConnectM Technology Solutions, Inc.8-Kpositivemateriality 9/10

18-03-2026

ConnectM Technology Solutions, Inc. (CNTM) acquired Harry Kahn Associates, Inc. (HKA), an 80-year-old defense contractor specializing in logistics data systems for U.S. military platforms, by issuing 400,000 shares of common stock. HKA generated approximately $2M in revenue in 2025 and is expected to scale significantly by integrating with ConnectM's Keen Labs AI platform to target the $50B+ global defense sustainment market. No prior period comparisons or declines were disclosed, positioning the acquisition for expansion in government and defense sectors.

  • ·HKA founded in 1943 with ISO 9001:2015 certification
  • ·HKA supports U.S. Department of Defense, U.S. Coast Guard, Navy, Marine Corps, Air Force, Army, and major defense OEMs
  • ·Acquisition expands ConnectM into long-duration government programs with 20-40 year military platform lifecycles
ECD Automotive Design, Inc.8-Knegativemateriality 9/10

18-03-2026

ECD Automotive Design, Inc. issued additional senior secured convertible notes with $2.66M principal (purchase price $2.42M) to its parent Holder on March 12, 2026, under a prior June 2025 SPA with up to $22.0M aggregate principal, increasing total outstanding principal from the Holder to $12.48M; the notes mature December 12, 2026, and are convertible into up to 783.5M shares at a $0.0034 floor price, capped at 9.99% beneficial ownership. Following a merger on March 12, 2026, outstanding IPO warrants were adjusted to $0.0176 cash per share against a $2300 exercise price, rendering them worthless.

  • ·Notes exempt from registration under Section 4(a)(2) and Rule 506 of Regulation D.
  • ·Holder exercised right under June 5, 2025 securities purchase agreement.
  • ·Warrant adjustment pursuant to Section 4.5 of warrant agreement post-merger effective March 12, 2026.
Unknown8-Kneutralmateriality 6/10

18-03-2026

BMO Commercial Mortgage Securities LLC filed an 8-K on March 18, 2026, disclosing the transfer of servicing for the U-Haul Portfolio Whole Loan (including the U-Haul Portfolio Mortgage Loan) from the BBCMS 2025-C39 PSA to the Benchmark 2026-B42 Pooling and Servicing Agreement, effective March 12, 2026, upon contribution to the Benchmark 2026-B42 Securitization. The new servicing terms include a special servicing fee of 0.25% per annum (minimum $3,500 monthly), workout fee of 1% (minimum $25,000, maximum $1,000,000), and liquidation fee of 1% (minimum $25,000, maximum $1,000,000). Property inspections for the portfolio are required at least every 12 months (for allocated loan amounts >= $2,000,000) or 24 months (for smaller amounts), commencing in 2027.

  • ·BBCMS 2025-C39 PSA filed January 29, 2026 under File No. 333-280224-12
  • ·Prospectus filed January 29, 2026 pursuant to Rule 424(b)(2) under File No. 333-280224-12
CIM REAL ESTATE FINANCE TRUST, INC.8-Kneutralmateriality 7/10

18-03-2026

CIM Real Estate Finance Trust, Inc., as guarantor, along with its subsidiaries entered into the Fifth Amendment to the Master Repurchase and Securities Contract with Wells Fargo Bank, National Association, dated March 12, 2026, primarily updating the definition of the Fee Letter to a Fifth Amended and Restated version. The amendment reaffirms that all existing obligations, liens, and security interests under the original agreement (dated May 20, 2021, with prior amendments) remain in full force without modification or reduction, and no Defaults or Events of Default exist. Seller agrees to pay Buyer's reasonable legal fees from Moore & Van Allen, PLLC, per invoice.

  • ·Original Master Repurchase Agreement dated May 20, 2021
  • ·Prior amendments: October 28, 2021 (First); February 14, 2022 (Amended and Restated Confirmation effective December 23, 2021); March 4, 2022 (Second); August 31, 2022 (Third); August 15, 2025 (Fourth)
  • ·Legal fees payable within 10 Business Days of invoice if not paid at closing
Newton Golf Company, Inc.8-Kneutralmateriality 8/10

18-03-2026

Newton Golf Company, Inc. (NWTG) entered into a Securities Purchase Agreement dated March 2026 to issue convertible promissory notes and warrants to accredited investors for an aggregate principal amount of up to $2.0 million across initial and additional closings. The Notes are convertible into shares of Common Stock (par value $0.01), and Warrants are exercisable for additional Common Stock shares. No financial performance metrics or period-over-period comparisons are provided in the filing.

  • ·Filing date: March 18, 2026
  • ·SEC 8-K Items: 1.01 (Entry into Material Definitive Agreement), 2.03 (Creation of Direct Financial Obligation), 3.02 (Unregistered Sales of Equity Securities), 9.01 (Financial Statements and Exhibits)
  • ·Common Stock par value: $0.01 per share
  • ·Purchasers are accredited investors; securities offered under exemptions from federal and state securities registration

Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 31 filings

🇺🇸 More from United States

View all →
US Corporate Distress Financial Stress SEC Filings — March 18, 2026 | Gunpowder Blog